Details for New Drug Application (NDA): 075280
✉ Email this page to a colleague
The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
Summary for 075280
Tradename: | NABUMETONE |
Applicant: | Chartwell Rx |
Ingredient: | nabumetone |
Patents: | 0 |
Pharmacology for NDA: 075280
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 075280
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NABUMETONE | nabumetone | TABLET;ORAL | 075280 | ANDA | Chartwell RX, LLC | 62135-145 | 62135-145-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-145-60) |
NABUMETONE | nabumetone | TABLET;ORAL | 075280 | ANDA | Chartwell RX, LLC | 62135-146 | 62135-146-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-146-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Feb 25, 2002 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Feb 25, 2002 | TE: | AB | RLD: | No |
Complete Access Available with Subscription